NextCure, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXTC research report →
About the company
NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function.
- CEO
- Michael S. Richman
- IPO
- 2019
- Employees
- 43
- HQ
- Beltsville, MD, US
Price Chart
- Market Cap
- $5.04M
- P/E
- -0.10
- P/S
- 0.00
- P/B
- 0.37
- EV/EBITDA
- 0.10
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -186.96%
- ROIC
- -174.59%
- Revenue
- $0 · 0.00%
- Net Income
- $-55,844,000 · -0.34%
- EPS
- $-19.65 · 17.71%
- Op Income
- $-57,616,000
- FCF YoY
- -20.19%
- 52W High
- $15.74
- 52W Low
- $1.55
- 50D MA
- $6.06
- 200D MA
- $9.66
- Beta
- 1.30
- Avg Volume
- 99.81K
Get TickerSpark's AI analysis on NXTC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | Feigal Ellen | other | 2,340 |
| Jun 18, 26 | Jones Elaine V | other | 2,340 |
| Jun 18, 26 | Borgman Anne Elizabeth | other | 2,340 |
| Jun 18, 26 | Webster Stephen W | other | 2,340 |
| Jun 18, 26 | KABAKOFF DAVID S | other | 3,510 |
| Jun 18, 26 | Houston John G | other | 2,340 |
| Jan 30, 26 | Shaw Kevin G. | other | 8,270 |
| Jan 30, 26 | Guha Udayan | other | 14,670 |
| Jan 30, 26 | Kundu Sourav | other | 8,270 |
| Jan 30, 26 | Mayer Timothy | other | 14,670 |
Our NXTC coverage
Recent articles, reports, and earnings notes.
No research on NXTC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NXTC report →Similar companies
Peers in the same neighborhood.